Two established changes potentially affecting the activity of this pathway in TCC are hypermethylation of the APC promoter and diminished expression of E-cadherin, caused by CDH1 hypermethylation or mutation. The gene discussed is CDH1; the disease is tarsal-carpal coalition syndrome.